Profusa, Inc. (PFSA)

CIK 0001859807 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)
—
Consolidated Statements of Operations
Unaudited Condensed Consolidated Statements of Operations
—
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (P)
—
Consolidated Statements of Operations (P)
Unaudited Condensed Consolidated Statements of Changes In Stockholders Deficit
—
Unaudited Condensed Consolidated Statements of Operations (P)
—
Consolidated Statements of Changes In Stockholders Deficit
Consolidated Statements of Convertible Preferred Stock and Stockholders Deficit
Unaudited Condensed Consolidated Statements of Cash Flows
—
Consolidated Statements of Cash Flows
Notes
Balance Sheet Components
Commitments and Contingencies
Common Stock Warrants
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Description of Organization and Business Operations
Fair Value Measurement
Income Taxes
—
Initial Public Offering
Insider Trading Arrangements
Net Loss Per Share Attributable To Common Stockholders
Organization, Description of Business, Going Concern and Significant Risks and Uncertainties
Pay Vs Performance Disclosure
Private Placement
Recapitalization
Related Party Transactions
Revision of Third Quarter 2025
—
Segment Information
Segments
Significant Accounting Policies
—
Stock Option Plan
Stockholders' Deficit
Subsequent Events
Summary of Significant Accounting Policies
Warrants
—